StageZero Life Sciences SZLSF Stock
StageZero Life Sciences Price Chart
StageZero Life Sciences SZLSF Financial and Trading Overview
| StageZero Life Sciences stock price | 0.0051 USD |
| Previous Close | 0.0051 USD |
| Open | 0.01 USD |
| Bid | 0.02 USD x 0 |
| Ask | 0.02 USD x 2000000 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.0005 - 0.03 USD |
| Volume | 300 USD |
| Avg. Volume | 17 USD |
| Market Cap | 630.02K USD |
| Beta (5Y Monthly) | 0.299 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SZLSF Valuation Measures
| Enterprise Value | 2.75M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.21858548 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.954 |
| Enterprise Value/EBITDA | -0.616 |
Trading Information
StageZero Life Sciences Stock Price History
| Beta (5Y Monthly) | 0.299 |
| 52-Week Change | 70.00% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.03 USD |
| 52 Week Low | 0.0005 USD |
| 50-Day Moving Average | 0.005008 USD |
| 200-Day Moving Average | 0.004294 USD |
SZLSF Share Statistics
| Avg. Volume (3 month) | 17 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 123.53M |
| Float | 110.99M |
| Short Ratio | N/A |
| % Held by Insiders | 19.99% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2024 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -70.47% |
| Gross Margin | 1.04% |
| EBITDA Margin | -154.87% |
Management Effectiveness
| Return on Assets (ttm) | -63.79% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.88M USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | -33.00000000000000000000000000000000% |
| Gross Profit (ttm) | 29.99K USD |
| EBITDA | -4463997 USD |
| Net Income Avi to Common (ttm) | -12533373 USD |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.03K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 2.13M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.036 |
| Book Value Per Share (mrq) | -0.09 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -809155 USD |
| Levered Free Cash Flow (ttm) | 1.18M USD |
Profile of StageZero Life Sciences
| Country | United States |
| State | ON |
| City | Richmond Hill |
| Address | 70 East Beaver Creek Road |
| ZIP | L4B 3B2 |
| Phone | N/A |
| Website | https://www.stagezerolifesciences.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 40 |
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer detection panel that tests blood for multiple discrete cancer. It also offers ColonSentry, a blood-based test to determine an individual's current risk for having colorectal cancer. The company is based in Richmond Hill, Canada.
Q&A For StageZero Life Sciences Stock
What is a current SZLSF stock price?
StageZero Life Sciences SZLSF stock price today per share is 0.0051 USD.
How to purchase StageZero Life Sciences stock?
You can buy SZLSF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for StageZero Life Sciences?
The stock symbol or ticker of StageZero Life Sciences is SZLSF.
Which industry does the StageZero Life Sciences company belong to?
The StageZero Life Sciences industry is Diagnostics & Research.
How many shares does StageZero Life Sciences have in circulation?
The max supply of StageZero Life Sciences shares is 123.53M.
What is StageZero Life Sciences Price to Earnings Ratio (PE Ratio)?
StageZero Life Sciences PE Ratio is now.
What was StageZero Life Sciences earnings per share over the trailing 12 months (TTM)?
StageZero Life Sciences EPS is -0.12 USD over the trailing 12 months.
Which sector does the StageZero Life Sciences company belong to?
The StageZero Life Sciences sector is Healthcare.